Alto Neuroscience
ANRO
ANRO
58 hedge funds and large institutions have $199M invested in Alto Neuroscience in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+5
Holders Change %
+9.43%
% of All Funds
0.84%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
18
Increased
21
Reduced
10
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Alkeon Capital Management
New York
|
+$9.99M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$7.48M |
| 3 |
BlackRock
New York
|
+$4.59M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$3.96M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$2.45M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.67M |
| 2 |
ZP
Zimmer Partners
New York
|
-$1.15M |
| 3 |
Millennium Management
New York
|
-$1.09M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$944K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$801K |
